GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Cash Flow from Others

Ectin Research AB (XSAT:ECTIN B) Cash Flow from Others : kr9.11 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Cash Flow from Others?

Ectin Research AB's cash flow from others for the three months ended in Mar. 2024 was kr-0.01 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2024 was kr9.11 Mil.


Ectin Research AB Cash Flow from Others Historical Data

The historical data trend for Ectin Research AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Cash Flow from Others Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Cash Flow from Others
- -0.01 - 9.12

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 - 9.14 -0.01

Ectin Research AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.11 Mil.

Ectin Research AB Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines